Table 6.
Relationship between MTA1 expression and clinical characteristics (Fisher's exact test).
| Characteristics | Low expression |
High expression |
p value | |||
|---|---|---|---|---|---|---|
| N | n | % | n | % | ||
| Gender | 1 | |||||
| Male | 17 | 5 | 29.4% | 12 | 70.6% | |
| Female | 13 | 4 | 30.8% | 9 | 69.2% | |
| Age | 1 | |||||
| <18 | 22 | 7 | 31.8% | 15 | 68.2% | |
| ≧18 | 8 | 2 | 25.0% | 6 | 75.0% | |
| Ennecking stage | 0.0289 | |||||
| Ⅱ | 21 | 9 | 42.9% | 12 | 57.1% | |
| Ⅲ | 9 | 0 | 0 | 9 | 100% | |
| Metastasis at diagnosis | 0.0289 | |||||
| Negative | 21 | 9 | 42.9% | 12 | 57.1% | |
| Positive | 9 | 0 | 0 | 9 | 100% | |
| Response to neoadjuvant | 0.6662 | |||||
| Positive | 21 | 6 | 28.6% | 15 | 71.4% | |
| Negative | 9 | 3 | 33.3% | 6 | 66.6% | |